Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3795_Библиотеки_им_академика_М_И_Перельмана-1

the advent of clinical cardiopulmonary bypass in 1954 and 1955. At first, aortic valvotomy and removal of calcific deposits were all that could be acchieved [9, 10]. Then Bahnson and colleagues and, independently, Hufnagel and Conrad developed a single-leaflet prosthesis that was commercialized [11, 12]. Generally, the leaflets were used to partially replace the aortic valve, but three leaflets could be used together for total aortic valve replacement. Probably the first single-unit prosthesis for total aortic valve replacement was the polytetrafluroethylene (PTFE) sleeve prosthesis developed and first used by McGoon at the Mayo Clinic in 1961. Introduction of the ball valve prosthesis by Harken and colleagues and Starr and colleagues in 1960 and reported in 1963 established aortic valve surgery on a firm basis [13, 14]. Many types of prosthetic valves have subsequently developed. In 1956, Murray demonstrated that the aortic valve could be used as an allograft valve transplant in the descending thoracic aorta in patients with aortic regurgitation, [15] and Kerwin and colleagues reported 6-year follow­up [16]. The first orthotopic insertions of an allograft valve using the double-suture-line technique were performed in 1962 by Barratt-Boyes and separately by Ross using a single­sutureline technique described by Duran and Gunning [17, 18]. In 1967, Ross and colleagues introduced the pulmonary autograft for aortic valve replacement [19]. In 1965, Binet and colleagues in Paris implanted porcine xenograft aortic valves, sterilized and preserved in a special formaldehyde solution, directly into the aortic root [20]. Stent-mounted bioprostheses are manufactured to provide a standard device that is easily implanted and provides reproducible results in the aortic position. Glutaraldehyde preserved stent-mounted porcine valves were introduced by Carpentier and colleagues in Paris in 1967 [21]. David and colleagues revived the concept of direct insertion of nonstented porcine xenografts into the aortic root [22]. This valve was manufactured on a limited trial basis by Hancock Laboratory and by St. Jude Medical as the Toronto SPV (stentless porcine valve). In April 2002, Professor Alan Cribier at the University of Rouen, France, performed the first percutaneous aortic valve implantation for aortic stenosis in a 62-year-old man who was not a candidate for surgery [23]. Cribier used the antegrade transseptal approach through the femoral vein. Frirst transapical approach was used by Lange et al. [24] in 2007 with successful implantation of suturles Corevalve (Medtronic Inc). First suturless aortic valve Shrestha et al. [25] have describe first implantation of Perceval suturless valve implatation in human. All the timeline related to surgical treatment of aortic valve is designed in Figure 1.